Healio featured several September JDD studies in its recent dermatology news coverage including a study on using fractional lasers for skin cancer prevention. The study, “Fractional Laser for Prevention of…
Read More
Dermatology Times featured a JDD study on whether race plays a factor in access to biologics. The study, “No Racial Differences Found in Access to Biologics: A Population-Based Study of…
Read More
Healio featured a JDD study on the use of tildrakizumab for plaque psoriasis. Jayme Heim, MSN, FNP-BC, and colleagues wrote, “Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe…
Read More
Sponsored by Join the Journal of Drugs in Dermatology and Nutrafol in recognizing Hair Loss Awareness Month this August. This month aims to raise awareness how common hair thinning…
Read More
Click Here to View Video Abstract Importance: Managing chronic conditions is an essential aspect of dermatologic care, especially regarding the resolution of inflammatory dermatologic disease and recovery of skin lesions. Short-term…
Read More
Click Here to Watch Video Abstract Background: Patients with skin of color (SOC), defined as Fitzpatrick skin types IV to VI, and of varying ethnicities are under-represented in dermatology. This…
Read More
Healio covered a JDD study on the impact of an increased dose of adalimumab in hidradenitis suppurativa patients who are overweight or obese. Researchers from the University of California San…
Read More
Healio wrote about several JDD studies in recent weeks including one on using gene expression profiling (GEP) in managing skin cancer. Ryan Jay, DO, and colleagues authored, “Utility of Gene…
Read More
The dermatology trade press featured several JDD articles about pigmentary disorders in recent weeks. Dermatology Times reported on a JDD study in its article about comorbidities in vitiligo. The study,…
Read More
Allure featured a JDD study in its article about inclusivity in cosmetic procedures. The study, “Understanding the Female African American Facial Aesthetic Patient,” by Andrew Alexis, MD, MPH, and colleagues,…
Read More
Dermatology Times and Dermatology Advisor each featured a February JDD study about topical clascoterone for facial acne vulgaris. The study, “Efficacy and Safety of 1% Clascoterone Cream in Patients Aged…
Read More
The JDD Podcast, Ask the Investigator, has released six episodes highlighting research tales from Pfizer Grant awardees. In each episode, Dr. Adam Friedman discusses the grant awardees journey. See below and…
Read More
